Table 1.
| Patient no. |
Age (y) |
PSA at baseline |
Gleason Score |
KPS | No. of PET Scans |
Site of Disease | Therapeutic Regimen |
|---|---|---|---|---|---|---|---|
| 1 | 65 | 885.05 | 9 | 80 | 3 | Bone | Docetaxel (Sanofi-Aventis) |
| 2 | 68 | 96.62 | 10 | 80 | 3 | Bone, Lymph Node, Prostatic Mass, Soft Tissue |
Docetaxel (Sanofi-Aventis) |
| 3 | 75 | 10.44 | 5 | 90 | 1 | Bone | 17AAG (AG Scientific), Docetaxel (Sanofi-Aventis) |
| 4 | 73 | 24.90 | 7 | 90 | 3 | Lymph Node | Abiraterone (Cougar Biotechnology) |
| 5 | 59 | 7.52 | 9 | 90 | 3 | Bone, Lymph Node | Abiraterone (Cougar Biotechnology) |
| 6 | 49 | 27.04 | 7 | 90 | 3 | Lymph Node | MDV3100 (Medivation, Inc) |
| 7 | 53 | 96.45 | 9 | 90 | 3 | Bone, Lymph Node | 17AAG (AG Scientific), Docetaxel (Sanofi-Aventis) |
| 8 | 74 | 47.22 | 7 | 80 | 2 | Bone | Docetaxel (Sanofi-Aventis) |
| 9 | 70 | 0.49 | 7 | 90 | 2 | Bone | 17AAG (AG Scientific), Docetaxel (Sanofi-Aventis) |
| 10 | 59 | 5.28 | 9 | 80 | 3 | Liver | Docetaxel (Sanofi-Aventis) |
| 11 | 76 | 10.42 | 6 | 90 | 2 | Bone | Palliative RT to Sacrum |
| 12 | 67 | 17.51 | 10 | 80 | 1 | Bone, Lymph Node, Liver | 5-Fluorouracil (Pharmacia and Upjohn), oxaliplatin (Sanofi-Aventis) |
| 13 | 79 | 1.52 | 7 | 80 | 1 | NA | Bicalutamide (AstraZeneca) |
*
Reading for patient 13 had a confidence of metastases of equivocal, therefore sites of disease were not identified.